Sienna Gestion Makes New Investment in Zoetis Inc. $ZTS

Sienna Gestion acquired a new stake in shares of Zoetis Inc. (NYSE:ZTS) during the third quarter, Holdings Channel reports. The fund acquired 43,685 shares of the company’s stock, valued at approximately $5,828,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. North Star Asset Management Inc. boosted its holdings in Zoetis by 4.9% during the 2nd quarter. North Star Asset Management Inc. now owns 1,441 shares of the company’s stock valued at $225,000 after acquiring an additional 67 shares during the period. Bank of Nova Scotia Trust Co. boosted its stake in shares of Zoetis by 4.6% during the second quarter. Bank of Nova Scotia Trust Co. now owns 1,692 shares of the company’s stock valued at $264,000 after purchasing an additional 74 shares during the period. RWA Wealth Partners LLC grew its holdings in shares of Zoetis by 2.7% in the second quarter. RWA Wealth Partners LLC now owns 2,852 shares of the company’s stock worth $445,000 after purchasing an additional 76 shares during the last quarter. Summit Place Financial Advisors LLC increased its stake in shares of Zoetis by 0.4% in the third quarter. Summit Place Financial Advisors LLC now owns 19,369 shares of the company’s stock worth $2,834,000 after buying an additional 76 shares during the period. Finally, First County Bank CT raised its holdings in Zoetis by 5.4% during the 3rd quarter. First County Bank CT now owns 1,535 shares of the company’s stock valued at $225,000 after buying an additional 79 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on ZTS. BTIG Research reissued a “buy” rating and issued a $160.00 price target on shares of Zoetis in a report on Thursday, February 26th. Morgan Stanley set a $160.00 price objective on shares of Zoetis in a research note on Thursday, December 18th. KeyCorp initiated coverage on shares of Zoetis in a report on Thursday, November 20th. They set a “sector weight” rating for the company. Barclays began coverage on Zoetis in a research note on Monday, December 8th. They issued an “equal weight” rating and a $136.00 target price on the stock. Finally, The Goldman Sachs Group raised Zoetis to a “buy” rating in a research report on Monday, December 15th. Six investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Zoetis presently has an average rating of “Hold” and an average price target of $152.91.

Zoetis Price Performance

ZTS opened at $121.54 on Monday. The stock has a fifty day simple moving average of $126.06 and a two-hundred day simple moving average of $132.88. The company has a current ratio of 3.03, a quick ratio of 1.94 and a debt-to-equity ratio of 2.71. The company has a market cap of $51.31 billion, a price-to-earnings ratio of 20.19, a price-to-earnings-growth ratio of 1.85 and a beta of 0.95. Zoetis Inc. has a 12-month low of $115.25 and a 12-month high of $177.00.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 12th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.40 by $0.08. The business had revenue of $2.39 billion during the quarter, compared to analyst estimates of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The company’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.40 earnings per share. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Research analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s dividend payout ratio (DPR) is 35.22%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.